Policy and Legislation
As American voters are weighing the differing proposals and positions of the top candidates this primary season, we thought we'd ask our readers of healthcare insiders who they think would be the best to lead the country from strictly a healthcare policy position.
As the Iowa caucus kicked off on Monday, candidates on both sides sparred over their plans for healthcare and the future of President Obama's Affordable Care Act in general.
Arkansas Gov. Asa Hutchinson is set to meet Monday with federal officials in Washington to negotiate the future of the state's Medicaid expansion program, which leading Republicans say could be killed if it's not changed.
Members of Congress, federal officials and health-policy experts agree that the Food and Drug Administration's surveillance system for devices is inadequate and relies too heavily on manufacturers to report problems with their own products.
California voters will weigh in this November on a high-stakes ballot proposition intended to help control the cost of prescription drugs - the latest attempt to limit soaring prices that have prompted public criticism nationwide.
The Centers for Medicare and Medicaid Services on Thursday said it will begin taking regional differences into account when measuring the performance of accountable care organizations in the Medicare Shared Savings program, one of several changes announced to the benchmark guidelines in the program.
Donald Trump is calling for a change in the way Medicare deals with big pharma prices, a revision long targeted by Democrats.
Healthcare has emerged as one of the flash points in the Democratic presidential race.
The Centers for Medicare and Medicaid Services on Thursday finalized a rule on the rebate and reimbursement of prescription drugs, a move aimed at bringing down consumer costs and which is expected to save federal and state governments an estimated $2.7 billion over five years.
Former Turing Pharmaceutical Chief Executive Martin Shkreli has invoked the Fifth Amendment by refusing to produce documents subpoenaed by a Senate committee investigating on prescription drug price hikes, according to NBC News and Twitter chatter between Shkreli and the chairwoman of the committee.